| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.00097 | 1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.00089 | 1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00064 | 1 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.00065 | 1 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.00046 | 1 |